Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (K23DK103911, U01DK074007, U01DK073974, U01DK073975)
National Institute of Diabetes and Digestive and Kidney Diseases (US) (U01DK074008)
Text and Data Mining valid from 2018-08-07
Received: 9 March 2018
Accepted: 23 July 2018
First Online: 7 August 2018
Ethics approval and consent to participate
: IRB approval obtained at all clinical sites and at Mayo Clinic as follows: Temple University Office for Human Subjects Protections (FWA00004964); California Pacific Medical Center Research Institute (FWA00000921); Texas Tech University Health Sciences Center (El Paso) (FWA 00006767); University of Mississippi Medical Center (FWA00003630) and Mayo Clinic (IRB 07–003371). Written informed consent was obtained for gastroparesis cases and verbal consent was obtained for controls as per approval by respective IRBs.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.